SRS Capital Advisors »

C4 Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $35 19 1.89
2025-09-30 $122 55 2.22

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)

View all positions for SRS Capital Advisors

Top funds holding C4 Therapeutics

Point72 Asset Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
OrbiMed Advisors
Vanguard Group
Daniel D. Thurber
Soleus Capital Management
Millennium Management
Silverarc Capital Management
BlackRock
Susquehanna International
Renaissance Technologies
Goldman Sachs Group
Geode Capital Management
Jane Street

View all funds holding C4 Therapeutics